Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,198,283
-$9,929,840 QoQ
Shares Held
56,423
-49.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#760
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Osmosis Investment Management UK Ltd holds $127,471,976 across 10 Drug Manufacturers - General names. ABBV ranks #5 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,430 | $26,903,217 | |
| 2 | AZN |
Astrazeneca PLC
|
105,982 | $20,096,306 | |
| 3 | JNJ |
Johnson & Johnson
|
78,182 | $19,855,882 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
289,321 | $16,670,676 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
56,423 | $14,198,283 | |
| 6 | AMGN |
Amgen Inc
|
32,649 | $11,822,855 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
90,311 | $11,409,891 | |
| 8 | MRK |
Merck & Co., Inc.
|
39,005 | $5,012,142 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,198,283 | 56,423 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,128,123 | 110,939 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,414,714 | 111,229 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||